Appleby Report (PDF 940KB)

Rapid review of Northern Ireland Health and Social Care funding needs and the productivity challenge: 2011/12-2014/15

Final Report Review of DHSSPS Training Support Funding For Social Care Voluntary Organisations February 2011 (PDF 368KB)

Review of DHSSPS Training Support Funding Programme For Social Care Voluntary Organisations

CMO Annual Report 2009 (PDF 3.78MB)

Chief Medical Officer Annual Report 2009

CMO Annual Report Tables 2009 (PDF 122KB)

Chief Medical Officer Tables 2009

Report of the Review of the Breastfeeding Strategy for Northern Ireland (PDF 341KB)

May-10

CMO Annual Report 2008 (PDF 4MB)

Chief Medical Officer Annual Report 2008

Strategic Resources Framework Report 2008/09 (PDF 532KB)

Strategic Resources Framework Report for 2008/09

Strategic Resources Framework Report 2008/09 - Appendices (PDF 892KB)

Appendices to the Strategic Resources Framework Report for 2008/09

Shooting up Report 2008 (PDF 1.6MB)

Shooting Up: Infections among injecting drug users in the United Kingdom 2007- An Update: October 2008

Strategies to promote translational research within the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Group: a report from the Translational Research Subcommittee.

Head and neck squamous cell cancer (HNSCC) is the sixth leading cause of cancer-related deaths worldwide. These tumors are commonly diagnosed at advanced stages and mortality rates remain high. Even cured patients suffer the consequences of aggressive treatment that includes surgery, chemotherapy, and radiotherapy. In the past, in clinical trials, HNSCC was considered as a single disease entity. Advances in molecular biology with the development of genomic and proteomic approaches have demonstrated distinct prognostic HNSCC patient subsets beyond those defined by traditional clinical-pathological factors such as tumor subsite and stage [Cho W (ed). An Omics Perspective on Cancer Research. New York/Berlin: Springer 2010]. Validation of these biomarkers in large prospective clinical trials is required before their clinical implementation. To promote this research, the European Organisation for Research and Treatment of Cancer (EORTC) Head and Neck Cancer Program will develop the following strategies-(i) biobanking: prospective tissue collection from uniformly treated patients in the setting of clinical trials; (ii) a group of physicians, physician-scientists, and EORTC Headquarters staff devoted to patient-oriented head and neck cancer research; (iii) a collaboration between the basic scientists of the Translational Research Division interested in head and neck cancer research and the physicians of the Head and Neck Cancer Group; and (iv) funding through the EORTC Grant Program and the Network Core Institutions Consortium. In the present report, we summarize our strategic plans to promote head and neck cancer research within the EORTC framework.

Northern Ireland Speech and Language Therapy Task Force report (PDF 1,016 KB)

Speech and Language task force report

Independent Review of Autism Services final report (PDF 565 KB)

Independent Review of Autism Services final report

NI 2007 Sight Test Survey Final Report (PDF 715KB)

2007 Sight Test Survey Report